The practitioner's encyclopedia of medical treatment / edited by W. Langdon Brown and J. Keogh Murphy.
- Date:
- 1915
Licence: Public Domain Mark
Credit: The practitioner's encyclopedia of medical treatment / edited by W. Langdon Brown and J. Keogh Murphy. Source: Wellcome Collection.
880/908 page 852
![Pysemia, venous, abscess of the lung during, 206 Pyzemia, septicemia, sapreemia, clinical distinctions between, 104 Pyelitis, acute cases, character- istics, 350; age incidence, 350; and cystitis, differentia] diag- nosis, 350, 360; febrile nature of, 350, 360; in children, age in- cidence, general and pyuric symp- toms and treatment, 350; mild cases, characteristics, 350; nature of the pyuria, 350; source and cause of infection, 349; nature and characteristics, 349, 350 Treatment: by autogenous vaccine, beneficial results of, 351; diet, beverages, and purga- tives in, 347, 350, 351; irriga- tion of pelvis inadmissible in, 351; reaction of urine in, importance of, 351 Pyelitis during pregnancy, diet in, 347; flushing of kidneys in, 347; irrigation of renal pelvis in, objections to, 347; operative measures, 347; patient’s position in bed in, 346; serum and vaccine treatment, 347; termination of pregnancy, 347 Pyelography, 348 Pyelonephritis, 351; ‘“‘ aseptic” form, causes, symptoms and causal treatment, 351; B. coli ascending infection causing, 351; due to calculi in both kidneys, treatment, 352; nature and char- acteristics, 349, 351; source and cause of infection, 349; sup- purative nature of, 351 Pyelonephritis, acute infective, 351; causes and characteristics, 351; chronic septic cystitis in relation to, 351; prognosis, gravity of, 352; treatment, medical and surgical, 352 Pyelonephritis, chronic, bilateral cases, percentage of, 352; ex- amination in, nature of, 352; general cause of, 352; urine in, characteristics, 352 Treatment: by autogenous vaccine, 353; of the septic cystitis, 352; surgical, 353 Pylethrombosis, cirrhosis of the liver commonest cause of, 329; symptoms and treatment, 329 Pylorus, action of acids on, 535; reflex closure of, how effected, 533 Pyogenic cocci, infections due to, serum treatment, 108 Pyogenic infections, eczema com- plicated by, 410 Pyonephrosis, causes and char- acteristics, 349, 351; channels of infection in, 349, 351; treat- ment, 351 Pyopericardium, surgical treatment of, 214 Pyorrhcea alveolaris, as factor in gastro-intestinal, diseases, treat- ment, 254; as infective focus of joint disease, 374; cases showing general toxemia, operative treat- ment, 255; classification of cases, 254; in pernicious anemia, 241; mouth wash for, 255; rarefying osteitis in, 254, 256; stomatitis in adults usually associated with, 256 Treatment : by vaccines, 256 ; classification of, 254-256 ; oper- ative and mechanical measures, 255-256; X-ray examination in, 255 Pyosalpinx, left, operation for, ap- pendicular changes following, case illustrating, 304 Pyramidon, formula, characteristics, 715; in influenza, 91; in migraine and periodic headache, 429; in palliative treatment of inoperable cancer, 18; therapeutic uses, 715; toxic symptoms and excretion, 715 Pyrantin, characteristics, action, and dosage, 714 Pyrazolon, formula and character- istics, 715; group of aromatic antipyretics, 715 Pyrethum, 748 Pyrexia, absent in primary in- testinal obstruction, 312; aconi- tine useful in, 683; control of, drugs in, indications for use, 86, 87; foreign substances in body fluids causing, 710; heart disease in relation to, 86; in tuberculosis, control of, 125, 126; of pneu- monia, treatment, 97; sustained treatment, continuous bath, pack, ice, and diaphoretics in, 87; treatment, principles of, 710, 711; treatment, periodical and incidental, 87-88 See also Antipyretics; Hyper- pyrexia; Fever. Pyrexial element of microbic in- toxication, 83 Pyrodin, characteristics and anti- pyretic action, 714 Pyrogallic acid, official preparations, 540; preparations for psoriasis, 412; therapeutical uses of, 540 Pyrogallol, characteristics, action, and uses, 709; use in skin affec- tions, 753 Pyrosis, magnesium peroxide useful for, 780 Pyrozone, composition of, and dosage, 780; and guaiacum a test for blood, 780 Pyuria, fever with, in man, usually prostatitis, 360; fever with, in women, always pyelitis, 360; in chronic pyelonephritis, 352, 353; in pyelitis, nature of, 350 Pyuria, chronic, medicinal treatment of, conditional danger of, 353 Quack medicines, 518 Quack methods of terminating pregnancy either ineffectual or fatal, 694 Qualimeter, in X-ray apparatus, 20, 21 Quassia, as a bitter ineffective in solid form, 733; infusion of, 523; infusion of, useful as enema in threadworms of children, 733; infusion of, preparation of, 733; official preparations of, dosage and characteristics, 732; toxic symptoms produced by, in ani- mals, 732 Quinaphenin, composition, action, and dosage of, 699 Quinaphthol, composition, and use as intestinal antiseptic, 699 Quinidine, composition and formula, 695 Quinine, action and internal ab- sorption of, 695; action on body heat, 696; action on respiratory and circulatory systems, 697; action on the blood, 696; action on unstriped muscle, 696; active principle of cinchona bark, dis- covery of, 136; as a bitter, 731; cinchonism symptoms produced by, 696 ; composition and formula, 695; disorders produced by, 696; during carbon dioxide snow treat- ment of lupus erythematosus, 62; effect on metabolism, 696; effect on nitrogenous secretion, 696; elimination by the kidneys, 695; in blackwater fever, 138; in chronic and acute lupus ery- thematosus, 417; in gradual bath treatment of hyperpyrexia of typhoid, 87; in fever of septic infections, 106; in leukemia, 245; in malignant endocarditis, 227; in rheumatic fever, in- effective, 110; intramuscular in- jection of, evoking latent tetanus, 114; official preparations and dosage, 700-701; poisoning by, symptoms of, 696; substances precipitating, 528 ; synthetic com- pounds of, soluble and insoluble, 699; therapeutical action, ex- ternal and internal, 696, 697; tolerance of internal organs to, 137 Treatment by: occurrence of tetanus following, 698; of Kala-Azar, directions for, 135; of malaria, directions for, 136; of malaria, methods of ad- ministration compared, 698; of malaria, reasons for, 517; of malaria, time for adminis- tering, 515; of cedematous eczema, 405; of pneumonia, 697; of neuralgia, 697; of whooping-cough, 697 Quinine, ammoniated tincture, value- less in influenza, 91 Quinine and strychnine, prepara- tions, formule, 642 Quinine and urea hydrochloride, therapeutic uses of, 699 Quinine salicylate, in influenza, 91 Quinine, salts of, table illustrating solubility in water and alcohol, alkaloidal content and dosage, 698; various preparations and their dosage, 700-701; varieties and choice of, 136 Quinine sulphate, substances in- compatible with, 530 Quinine-guaiacol-sulphonate, 699 Quinoline, formula, 704 Quinoline compounds, 705 ‘ Quinoline derivatives, possible causes of hemoglobinuria, 699](https://iiif.wellcomecollection.org/image/b32785720_0880.jp2/full/800%2C/0/default.jpg)
